NEW YORK (GenomeWeb News) — In vivo cellular-imaging company Mauna Kea Technologies will jointly promote its instruments with Invitrogen reagents.
 
Mauna Kea, headquartered both in Paris and Cambridge, Mass., said the combination of its fluorescent fiber optic microscopy with fluorescent reagents made by Invitrogen division Molecular Probes will allow customers to generate target images in living animals.   
 
Invitrogen said the pairing anticipates greater demand for molecular imaging.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.